Hyperion DeFi Overview
- Year Founded
-
2014
- Status
-
Public
- Employees
-
9
- Stock Symbol
-
HYPD
- Share Price
-
$2.08
- (As of Friday Closing)
Hyperion DeFi General Information
Description
Hyperion DeFi Inc is a USA-based company building a long-term strategic treasury of Hyperliquid's native token, HYPE. The Company is focused on providing its shareholders with simplified access to the Hyperliquid ecosystem, one of the fastest-growing and highest-revenue-generating blockchains in the world. Shareholders benefit from a gradually compounding exposure to HYPE, both from its native staking yield and additional revenues generated from its on-chain utility. It is working to provide its shareholders with simplified exposure to the Hyperliquid ecosystem, which is believed to be among the highest-revenue-generating blockchains in the world, according to information from various blockchain data tracking sources, including Artemis Analytics and DefiLlama.
Contact Information
Website
www.hyperiondefi.comCorporate Office
- 3090 Nowitzki Way
- Suite 300
- Dallas, TX 75219
- United States
Corporate Office
- 3090 Nowitzki Way
- Suite 300
- Dallas, TX 75219
- United States
Hyperion DeFi Timeline
Hyperion DeFi Stock Performance
As of 20-Nov-2026, Hyperion DeFi’s stock price is $2.08. Its current market cap is $31.7M with 15.2M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.08 | $2.34 | $2.01 - $4.99 | $31.7M | 15.2M | 418K | -$5.12 |
Hyperion DeFi Financials Summary
As of 30-Sep-2026, Hyperion DeFi has a trailing 12-month revenue of $1.91M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 57,470 | 29,364 | 22,092 | 87,060 |
| Revenue | 1,909 | 813 | 57 | 4 |
| EBITDA | 39,867 | (43,984) | (46,460) | (24,800) |
| Net Income | 39,611 | (45,314) | (49,818) | (27,261) |
| Total Assets | 146,290 | 51,764 | 3,668 | 28,779 |
| Total Debt | 712 | 8,515 | 11,241 | 16,081 |
Hyperion DeFi Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Hyperion DeFi Comparisons
Industry
Financing
Details
Hyperion DeFi Competitors (27)
One of Hyperion DeFi’s 27 competitors is Stablecoin Development, a Corporation company based in Emeryville, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Stablecoin Development | Corporation | Emeryville, CA | ||||
| Harrow | Corporation | Nashville, TN | ||||
| RVL Pharmaceuticals | Formerly PE-Backed | Bridgewater, NJ | ||||
| Viatris | Corporation | Canonsburg, PA | ||||
| Merck & Co. | Corporation | Rahway, NJ |
Hyperion DeFi Patents
Hyperion DeFi Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12419979-B2 | Pulsed ultraviolet in-line sterilization system for primary drug containers | Active | 03-Dec-2021 | ||
| US-20230173118-A1 | Pulsed ultraviolet in-line sterilization system for primary drug containers | Active | 03-Dec-2021 | ||
| AU-2020399803-A1 | Systems and devices for delivering fluids to the eye and methods of use | Inactive | 11-Dec-2019 | ||
| CA-3164288-A1 | Systems and devices for delivering fluids to the eye and methods of use | Pending | 11-Dec-2019 | ||
| EP-4072483-A1 | Systems and devices for delivering fluids to the eye and methods of use | Inactive | 11-Dec-2019 | A61F9/0008 |
Hyperion DeFi Signals
Hyperion DeFi ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
43.94 | Severe Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,593
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
Hyperion DeFi FAQs
-
When was Hyperion DeFi founded?
Hyperion DeFi was founded in 2014.
-
Where is Hyperion DeFi headquartered?
Hyperion DeFi is headquartered in Dallas, TX.
-
What is the size of Hyperion DeFi?
Hyperion DeFi has 9 total employees.
-
What industry is Hyperion DeFi in?
Hyperion DeFi’s primary industry is Drug Delivery.
-
Is Hyperion DeFi a private or public company?
Hyperion DeFi is a Public company.
-
What is Hyperion DeFi’s stock symbol?
The ticker symbol for Hyperion DeFi is HYPD.
-
What is the current stock price of Hyperion DeFi?
As of 20-Nov-2026 the stock price of Hyperion DeFi is $2.08.
-
What is the current market cap of Hyperion DeFi?
The current market capitalization of Hyperion DeFi is $31.7M.
-
What is Hyperion DeFi’s current revenue?
The trailing twelve month revenue for Hyperion DeFi is $1.91M.
-
Who are Hyperion DeFi’s competitors?
Stablecoin Development, Harrow, RVL Pharmaceuticals, Viatris, and Merck & Co. are some of the 27 competitors of Hyperion DeFi.
-
What is Hyperion DeFi’s annual earnings per share (EPS)?
Hyperion DeFi’s EPS for 12 months was -$5.12.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process